Radioembolization as an adjunct therapy to the resection of liver tumors

References

• Kennedy A , NagS, SalemRet al. Recommendations for radioembolization of hepatic malignancies using Yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int. J. Radiat. Oncol. Biol. Phys.68, 13–23 (2007).
   PubMed Web of Science ®Google Scholar
• Inarrairaegui M , SangroB. Results in hepatocellular carcinoma. In: Liver Radioembolization with 90Y Microspheres. BilbaoJI, ReiserMF ( Eds). Springer–Verlag, Berlin–Heidelberg, Germany, 105–117 (2013).
   Google Scholar
• Rodriguez J , ChopiteaA, SangroB, BilbaoJI. Results in liver metastatic colorectal cancer. In: Liver Radioembolization with 90Y Microspheres. BilbaoJI, ReiserMF ( Eds). Springer–Verlag, Berlin–Heidelberg, Germany, 141–148 (2013).
   Google Scholar
• Kennedy AS , McNeillieP, DezarnWAet al. Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors. Int. J. Radiat. Oncol. Biol. Phys.74(5), 1494–1500 (2009).
   PubMed Web of Science ®Google Scholar
• Sangro B , BilbaoJI, BoanJet al. Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma. Int. J. Radiat. Oncol. Biol. Phys.66(3), 792–800 (2006).
   PubMed Web of Science ®Google Scholar
• Hilgard P , HamamiM, FoulyAEet al. Radioembolization with Yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival. Hepatology52, 1741–1749 (2010).
   PubMed Web of Science ®Google Scholar
• Salem R , LewandowskiRJ, MulcahyMFet al. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology138, 52–64 (2010).
   PubMed Web of Science ®Google Scholar
• Mazzaferro V , SpositoC, BhooriSet al. Yttrium90 radioembolization for intermediate-advanced hepatocarcinoma: a Phase II study. Hepatology57(5), 1826–1837 (2013).
   PubMed Web of Science ®Google Scholar
• Lewandowski RJ , KulikLM, RiazAet al. A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. Am. J. Transplant.9, 1920–1928 (2009).
   PubMed Web of Science ®Google Scholar
• Iñarrairaegui M , PardoF, BilbaoJIet al. Response to radioembolization with Yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma. Eur. J. Surg. Oncol.38(7), 594–601 (2012).
   PubMed Web of Science ®Google Scholar
• Abdelfattah MR , Al-SebayelM, BroeringD, AlsuhaibaniH. Radioembolization using Yttrium-90 microspheres as bridging and downstaging treatment for unresectable hepatocellular carcinoma before liver transplantation: initial single-center experience. Transplant Proc.47(2), 408–411 (2015).
   PubMed Web of Science ®Google Scholar
• Padman S , PadburyR, BeekeCet al. Liver only metastatic disease in patients with metastatic colorectal cancer: impact of surgery and chemotherapy. Acta Oncol.52(8), 1699–1706 (2013).
   PubMed Web of Science ®Google Scholar
• Cosimelli M , GolfieriR, CagolPPet al. Multi-centre Phase II clinical trial of Yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases. Br. J. Cancer103(3), 324–331 (2010).
   PubMed Web of Science ®Google Scholar
• Golfieri R , MosconiC, GiampalmaEet al. Selective transarterial radioembolisation of unresectable liver-dominant colorectal cancer refractory to chemotherapy. Radiol. Med.120(8), 767–776 (2015).
   PubMed Web of Science ®Google Scholar
• Chopitea A , RodriguezJ, RodriguezMet al. Selective internal radiation therapy (SIRT) using Y90 resin microspheres as consolidation treatment for liver metastases from colorectal cancer (LCRC). J. Clin. Oncol.33(Suppl. 15), 3502 (2015).
   Web of Science ®Google Scholar
• Sharma RA , Van HazelGA, MorganBet al. Radioembolization of liver metastases from colorectal cancer using Yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J. Clin. Oncol.25(9), 1099–1106 (2007).
   PubMed Web of Science ®Google Scholar
• Gibbs P , HeinemannV, SharmaNet al. SIRFLOX: randomized Phase III trial comparing first-line mFOLFOX6 ± bevacizumab (bev) versus mFOLFOX6 + selective internal radiation therapy (SIRT) ± bev in patients (pts) with metastatic colorectal cancer (mCRC). J. Clin. Oncol.33(Suppl. 15), 3502 (2015).
   Google Scholar
• Fernandez-Ros N , SilvaN, BilbaoJIet al. Partial liver volume radioembolization induces hypertrophy in the spared hemiliver and no major signs of portal hypertension. HPB16(3), 243–249 (2014).
   PubMed Web of Science ®Google Scholar
• Gaba RC , LewandowskiRJ, KulikLMet al. Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar Yttrium-90 radioembolization. Ann. Surg. Oncol.16(6), 1587–1596 (2009).
   PubMed Web of Science ®Google Scholar
• Edeline J , LenoirL, BoudjemaKet al. Volumetric changes after (90)y radioembolization for hepatocellular carcinoma in cirrhosis: an option to portal vein embolization in a preoperative setting? Ann. Surg. Oncol. 20, 2518–2525 (2013).
   PubMed Web of Science ®Google Scholar
• Vouche M , LewandowskiRJ, AtassiRet al. Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. J. Hepatol.59, 1029–1036 (2013).
   PubMed Web of Science ®Google Scholar
• Fernandez-Ros N , IñarrairaeguiM, ParamoJAet al. Radioembolization of hepatocellular carcinoma activates liver regeneration, induces inflammation and endothelial stress and activates coagulation. Liver Int.35(5), 1590–1596 (2015).
   PubMed Web of Science ®Google Scholar
• Abulkhir A , LimongelliP, HealeyAJet al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann. Surg.247, 49–57 (2008).
   PubMed Web of Science ®Google Scholar
• Farges O , BelghitiJ, KianmaneshRet al. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann. Surg.237, 208–217 (2003).
   PubMed Web of Science ®Google Scholar
• Yang ZF , PoonRT, ToJet al. The potential role of hypoxia inducible factor 1alpha in tumor progression after hypoxia and chemotherapy in hepatocellular carcinoma. Cancer Res.64, 5496–5503 (2004).
   PubMed Web of Science ®Google Scholar
• Pardo F , SchoenM, Rheun-ChuanLet al. The Post-SIR-Spheres Surgery Study (P4S): analysis of outcomes following hepatic resection or transplantation in 101 patients previously treated with selective internal radiation therapy (SIRT). HPB17(Suppl. 1), 79 (2015).
   PubMedGoogle Scholar
• Bilbao JI , SangroB, SchoenMet al. The post-SIR-Spheres surgery study (P4S): analysis of outcomes following hepatic resection of patients previously treated with selective internal radiation therapy (SIRT), with or without exposure to future liver remnant (FLR). J. Vasc. Interv. Radiol.26(Suppl. 2), S90–S91 (2015).
   Google Scholar